Using the latest modular workflow technologies, SOM Biotech has released a new version of his proprietary drug repurposing virtual process. This update has had the goal to improve more than 30% the performance, scalability and velocity of the process.

This software update highlights the SOM Biotech strong commitment to grow day-by-day, in order to continue building a global leader in the field of Repurposing Drugs for Orphan Diseases.

If you are interested in a partnership or collaboration with, do not hesitate to get in touch.





    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.